Evidence map›Paper›PMID 24970824›Full record

ArticleGenome announcements2014

Genome Sequence of Streptomyces olindensis DAUFPE 5622, Producer of the Antitumoral Anthracycline Cosmomycin D.

Juan D Rojas, Antonio Starcevic, Damir Baranas̆ić, Maria A Ferreira-Torres, Camilo A Contreras, Leandro M Garrido, Welington L Araújo, Robson F de Souza, Jurica Zucko, Daslav Hranueli and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Genome announcements, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Unusual Sesquiterpenes fromJournal of natural products · 2024
    Article
  2. Article
  3. Frontiers in microbiology · 2019
    Article
  4. Frontiers in microbiology · 2018
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Juan D RojasInstitute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Antonio StarcevicFaculty of Food Technology and Biotechnology, University of Zagreb, Zagreb, Croatia.
Damir Baranas̆ićFaculty of Food Technology and Biotechnology, University of Zagreb, Zagreb, Croatia.
Maria A Ferreira-TorresInstitute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Camilo A ContrerasInstitute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Leandro M GarridoInstitute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Welington L AraújoInstitute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Robson F de SouzaInstitute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Jurica ZuckoFaculty of Food Technology and Biotechnology, University of Zagreb, Zagreb, Croatia.
Daslav HranueliFaculty of Food Technology and Biotechnology, University of Zagreb, Zagreb, Croatia.
Paul F Long
John CullumDepartment of Genetics, University of Kaiserslautern, Kaiserslautern, Germany.
Gabriel PadillaInstitute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil gpadilla@usp.br.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Streptomyces olindensis DAUFPE 5622, which was isolated from a Brazilian soil sample, produces the antitumor anthracycline cosmomycin D. The genome sequence is 9.4 Mb in length, with a G+C content of 71%. Thirty-four putative secondary metabolite biosynthetic gene clusters were identified, including the cosmomycin D cluster.

Identifiers

PMID24970824
PMCPMC4073108

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.